Back to top

200 Day Moving Average Support appears for CHRS after 1.2% move

Coherus BioSciences, Inc. (CHRS) Technical Analysis, Stock Scans & Trading Signals · Jul 8, 2026, 17:47 ET
CHRS finished lower by 1.2% on Wednesday, July 8th, trading 1.4 times its typical volume. Multiple bullish signals emerged — 200 DMA Support, Stochastic Reached Overbought & MACD Bullish Centerline Cross — suggesting potential strength ahead. Key support levels exist at 1.6, 1.56 & 1.51, with resistance at 1.69, 1.74 & 1.78. Additionally, Slow Stochastic points to overbought territory, hinting at a potential consolidation.

Current SwingTradeBot Technical Rating of CHRS: D

More charts, more signals, more insights—only on SwingTradeBot.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Coherus Oncology, Inc. (CHRS)